Drug Delivery

We need to step away from assumptions on device interchangeability and find out what patients really want.

Older adults are underrepresented in clinical trials. This needs to change.

Drug developers place their bets on the ROR-1 antigen in the battle against solid tumors.

The blood–brain barrier is a problem for most Alzheimer’s disease therapeutics, but ultrasound can help.

Lonza’s Enprotect Capsule is the recipient of The Medicine Maker 2023 Innovation Awards.

Diseases can affect men and women differently. We must acknowledge and accept that – and then optimize drug development accordingly

Self-propelled nanoparticles can reduce tumors in the bladder by 90 percent

Research sheds new light on cancer risk in gene therapies

How virus-based cancer therapeutic strategies could increase treatment efficacy

Can yeast-based vaccines help overcome global vaccine inequity challenges?